Share Price and Basic Stock Data
Last Updated: February 10, 2026, 10:39 pm
| PEG Ratio | 0.14 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Morgan Ventures Ltd operates in the Non-Banking Financial Company (NBFC) sector, with a current share price of ₹69.4 and a market capitalization of ₹68.7 Cr. The company’s revenue trajectory has shown volatility, with reported revenues of ₹7.04 Cr in September 2022, followed by a significant decline to -₹3.69 Cr in December 2022. However, this downward trend reversed in subsequent quarters, with revenues rising to ₹3.93 Cr by September 2023. The company recorded a notable revenue of ₹10.91 Cr in March 2024, which reflects a strong recovery and growth potential. In the trailing twelve months (TTM), revenues stood at ₹46 Cr, indicating a robust annual performance. The company’s ability to generate income from financing activities has been a crucial aspect, with financing profit recorded at ₹2.22 Cr in September 2023 and rising to ₹8.71 Cr by September 2024. This consistent increase in revenue generation highlights Morgan Ventures’ resilience and adaptability in the competitive financial landscape.
Profitability and Efficiency Metrics
Morgan Ventures has demonstrated strong profitability metrics, with a reported net profit of ₹23 Cr and an impressive return on equity (ROE) of 32%. The company’s profit margins have fluctuated, with a net profit of ₹1.98 Cr in September 2023 and escalating to ₹5.50 Cr in September 2024. The interest coverage ratio (ICR) stands at an extraordinary 9984.77x, indicating that the company can comfortably meet its interest obligations, which reflects robust operational efficiency. Moreover, the financing margin percentage exhibited significant variability, ranging from 56.49% in September 2023 to 85.82% in December 2024. Such margins are indicative of the company’s effective cost management and pricing strategies. However, the operating profit margin (OPM) remains unavailable, which limits comprehensive assessment. Overall, the firm’s ability to maintain profitability amidst operational challenges is commendable, positioning it well against industry peers.
Balance Sheet Strength and Financial Ratios
The balance sheet of Morgan Ventures reflects a solid financial foundation, with total assets amounting to ₹295 Cr as of September 2025. The company has reported reserves of ₹86 Cr, showcasing a strong capital base to support future growth initiatives. Notably, Morgan Ventures has maintained zero borrowings, which is a significant strength, allowing the company to operate without debt-related pressures. The price-to-book value (P/BV) ratio stands at a low 0.18x, indicating that the stock is potentially undervalued compared to its book value, which is a favorable sign for investors. Furthermore, the return on capital employed (ROCE) has improved to 18.3%, reflecting efficient utilization of capital in generating profits. However, the absence of gross and net non-performing asset (NPA) data raises concerns about potential asset quality issues. Overall, the company’s balance sheet indicates stability, but the lack of detailed asset quality metrics warrants caution.
Shareholding Pattern and Investor Confidence
Morgan Ventures exhibits a stable shareholding structure, with promoters holding a substantial 74.80% stake as of December 2025, indicating strong insider confidence in the company’s future prospects. Public shareholders account for 25.19%, and the total number of shareholders has increased from 4,290 in March 2023 to 6,125 by December 2025, reflecting growing interest from retail investors. This increase in shareholder base demonstrates a positive shift in market perception and investor confidence. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could indicate limited institutional interest, which may affect the stock’s liquidity and price stability. The consistent promoter holding suggests that the management is committed to the long-term growth of the company. Nonetheless, the reliance on a concentrated promoter stake could pose risks if the promoters’ interests diverge from those of minority shareholders.
Outlook, Risks, and Final Insight
The outlook for Morgan Ventures appears cautiously optimistic, given its strong profitability metrics and solid balance sheet. However, risks remain, particularly concerning operational volatility as evidenced by fluctuating revenues and profit margins. The company’s ability to sustain its revenue growth trajectory will be critical, especially if it faces increased competition in the NBFC sector. Additionally, the lack of detailed NPA data could pose risks related to asset quality, which could affect profitability. The absence of institutional investors may also limit the stock’s appeal to a broader investor base. Nonetheless, strengths such as high ROE, zero borrowings, and a strong promoter commitment present a compelling case for potential investors. If the company successfully addresses its operational challenges and enhances transparency regarding asset quality, it could emerge as a strong player in the financial services landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 13.3 Cr. | 1.33 | 1.66/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 6.42 Cr. | 0.64 | 4.08/0.58 | 18.9 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 389 Cr. | 59.8 | 125/44.0 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.9 Cr. | 16.2 | 24.7/14.8 | 12.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 28.8 Cr. | 63.9 | 138/57.6 | 15.5 | 238 | 1.56 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,720.71 Cr | 393.63 | 73.70 | 514.92 | 0.22% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.04 | -3.69 | -0.36 | 3.59 | 3.93 | 4.56 | 10.91 | 5.89 | 12.55 | 14.46 | 12.42 | 5.53 | 13.96 |
| Interest | 0.35 | 0.54 | 0.85 | 1.46 | 1.61 | 2.04 | 3.62 | 2.36 | 3.72 | 1.99 | 4.22 | 2.76 | 5.08 |
| Expenses | 0.07 | 0.07 | 2.12 | 0.08 | 0.10 | 0.06 | 0.17 | 0.83 | 0.12 | 0.06 | 0.33 | 2.11 | 0.08 |
| Financing Profit | 6.62 | -4.30 | -3.33 | 2.05 | 2.22 | 2.46 | 7.12 | 2.70 | 8.71 | 12.41 | 7.87 | 0.66 | 8.80 |
| Financing Margin % | 94.03% | 116.53% | 925.00% | 57.10% | 56.49% | 53.95% | 65.26% | 45.84% | 69.40% | 85.82% | 63.37% | 11.93% | 63.04% |
| Other Income | 0.00 | 0.77 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 1.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 6.62 | -3.53 | -3.33 | 2.06 | 2.23 | 2.46 | 7.12 | 4.09 | 8.71 | 12.41 | 7.87 | 0.66 | 8.80 |
| Tax % | 11.33% | -25.21% | -18.32% | 35.92% | 11.66% | 25.20% | 32.44% | -22.49% | 36.97% | 25.14% | 14.87% | -57.58% | 32.84% |
| Net Profit | 5.87 | -2.64 | -2.72 | 1.32 | 1.98 | 1.84 | 4.81 | 5.01 | 5.50 | 9.28 | 6.70 | 1.05 | 5.91 |
| EPS in Rs | 5.93 | -2.67 | -2.75 | 1.33 | 2.00 | 1.86 | 4.86 | 5.06 | 5.56 | 9.37 | 6.77 | 1.06 | 5.97 |
| Gross NPA % | |||||||||||||
| Net NPA % |
Last Updated: February 1, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for Morgan Ventures Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Interest, as of Sep 2025, the value is 5.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.76 Cr. (Jun 2025) to 5.08 Cr., marking an increase of 2.32 Cr..
- For Expenses, as of Sep 2025, the value is 0.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.11 Cr. (Jun 2025) to 0.08 Cr., marking a decrease of 2.03 Cr..
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 8.80 Cr.. The value appears strong and on an upward trend. It has increased from 0.66 Cr. (Jun 2025) to 8.80 Cr., marking an increase of 8.14 Cr..
- For Tax %, as of Sep 2025, the value is 32.84%. The value appears to be increasing, which may not be favorable. It has increased from -57.58% (Jun 2025) to 32.84%, marking an increase of 90.42%.
- For Net Profit, as of Sep 2025, the value is 5.91 Cr.. The value appears strong and on an upward trend. It has increased from 1.05 Cr. (Jun 2025) to 5.91 Cr., marking an increase of 4.86 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.97. The value appears strong and on an upward trend. It has increased from 1.06 (Jun 2025) to 5.97, marking an increase of 4.91.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 1 | -0 | -0 | 0 | -3 | 1 | 6 | 17 | 12 | 23 | 45 | 46 |
| Expenses | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 | 3 |
| Operating Profit | 3 | -1 | -0 | -0 | -0 | -3 | 1 | 6 | 15 | 10 | 23 | 44 | 44 |
| OPM % | 63% | -196% | -2,900% | 77% | 95% | 91% | 81% | 98% | 97% | 94% | |||
| Other Income | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 1 | -0 | 1 | 0 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 3 | 4 | 2 | 9 | 12 | 14 |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 |
| Profit before tax | 2 | -1 | 0 | 0 | 0 | -3 | -0 | 3 | 11 | 8 | 14 | 33 | 30 |
| Tax % | 1% | 65% | 17% | 33% | -0% | -27% | 100% | 50% | 25% | 19% | 28% | 23% | |
| Net Profit | 2 | -2 | 0 | 0 | 0 | -2 | -0 | 1 | 8 | 7 | 10 | 26 | 23 |
| EPS in Rs | 1.55 | -2.25 | 0.06 | 0.03 | 0.01 | -2.30 | -0.10 | 1.47 | 8.44 | 6.65 | 10.05 | 25.88 | 23.17 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 700.00% | -12.50% | 42.86% | 160.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 600.00% | -712.50% | 55.36% | 117.14% |
Morgan Ventures Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 108% |
| 3 Years: | 40% |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 201% |
| 3 Years: | 43% |
| TTM: | 65% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 56% |
| 3 Years: | 18% |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 32% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: February 1, 2026, 3:03 am
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 31 | 29 | 29 | 29 | 29 | 28 | 27 | 29 | 37 | 44 | 54 | 79 | 86 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 36 | 108 | 156 | 156 | 171 | 178 |
| Other Liabilities | 12 | 10 | 9 | 0 | 0 | 0 | 0 | 1 | 4 | 6 | 9 | 17 | 20 |
| Total Liabilities | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 278 | 295 |
| Fixed Assets | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 20 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 9 | 11 | 9 | 2 | 2 | 0 | 51 | 53 | 139 | 197 | 210 | 255 | 268 |
| Other Assets | 35 | 38 | 39 | 37 | 37 | 37 | 24 | 23 | 20 | 19 | 19 | 3 | 7 |
| Total Assets | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 278 | 295 |
Below is a detailed analysis of the balance sheet data for Morgan Ventures Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 86.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 86.00 Cr., marking an increase of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 295.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 278.00 Cr. (Mar 2025) to 295.00 Cr., marking an increase of 17.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 268.00 Cr.. The value appears strong and on an upward trend. It has increased from 255.00 Cr. (Mar 2025) to 268.00 Cr., marking an increase of 13.00 Cr..
- For Other Assets, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 4.00 Cr..
- For Total Assets, as of Sep 2025, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2025) to 295.00 Cr., marking an increase of 17.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 3.00 | -1.00 | 0.00 | 0.00 | 0.00 | -3.00 | -37.00 | -30.00 | -93.00 | -146.00 | -133.00 | -127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Inventory Days | -2,230 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 72 | 0 | 0 | -2,230 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Working Capital Days | 1,361 | 11,065 | 658,460 | 4,421 | 7,347 | 1,441 | 415 | 539 | 282 | -6 | ||
| ROCE % | 4% | -3% | 0% | 0% | 0% | -8% | 2% | 7% | 13% | 5% | 11% | 18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Jun 14 | Jun 13 | Jun 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
| Diluted EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
| Cash EPS (Rs.) | 0.06 | -2.12 | 2.56 | 1.08 | 2.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.54 | 4.18 | 4.13 | 4.00 |
| PBDIT / Share (Rs.) | 0.01 | -1.34 | 2.84 | 0.88 | 2.92 |
| PBIT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.19 | 1.83 |
| PBT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.58 | 1.17 |
| Net Profit / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
| NP After MI And SOA / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
| PBDIT Margin (%) | 0.00 | -246.91 | 68.05 | 21.43 | 73.09 |
| PBIT Margin (%) | 0.00 | -281.26 | 42.39 | -4.83 | 45.73 |
| PBT Margin (%) | 0.00 | -281.31 | 42.38 | -14.09 | 29.19 |
| Net Profit Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
| NP After MI And SOA Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
| Return on Networth / Equity (%) | 0.10 | -5.89 | 3.59 | 0.00 | 4.29 |
| Return on Capital Employeed (%) | 0.00 | -3.15 | 3.11 | -0.35 | 3.11 |
| Return On Assets (%) | 0.08 | -4.60 | 2.46 | 0.00 | 2.83 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.15 | 0.15 | 0.21 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.17 | 0.15 | 0.21 |
| Asset Turnover Ratio (%) | 0.00 | 0.01 | 0.07 | 0.07 | 0.07 |
| Current Ratio (X) | 2.49 | 13.52 | 5.19 | 8.13 | 11.95 |
| Quick Ratio (X) | 0.62 | 3.61 | 0.27 | 0.60 | 1.73 |
| Interest Coverage Ratio (X) | 67.43 | -4912.48 | 9984.77 | 2.31 | 4.42 |
| Interest Coverage Ratio (Post Tax) (X) | -11.85 | -8831.33 | 6145.96 | 0.38 | 3.59 |
| Enterprise Value (Cr.) | 7.47 | -1.79 | 14.72 | 11.69 | 11.19 |
| EV / Net Operating Revenue (X) | 0.00 | -3.32 | 3.56 | 2.86 | 2.81 |
| EV / EBITDA (X) | 404.43 | 1.35 | 5.23 | 13.33 | 3.84 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 8.13 | 1.88 | 1.50 | 0.73 |
| Price / BV (X) | 0.33 | 0.11 | 0.18 | 0.15 | 0.07 |
| Price / Net Operating Revenue (X) | 0.00 | 8.14 | 1.88 | 1.50 | 0.73 |
| EarningsYield | 0.00 | -0.52 | 0.19 | 0.00 | 0.58 |
After reviewing the key financial ratios for Morgan Ventures Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Diluted EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Cash EPS (Rs.), as of Mar 16, the value is 0.06. This value is below the healthy minimum of 3. It has increased from -2.12 (Mar 15) to 0.06, marking an increase of 2.18.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 0.00. It has decreased from 0.54 (Mar 15) to 0.00, marking a decrease of 0.54.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -1.34 (Mar 15) to 0.01, marking an increase of 1.35.
- For PBIT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For PBT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For PBDIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -246.91 (Mar 15) to 0.00, marking an increase of 246.91.
- For PBIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.26 (Mar 15) to 0.00, marking an increase of 281.26.
- For PBT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.31 (Mar 15) to 0.00, marking an increase of 281.31.
- For Net Profit Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 8. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.10. This value is below the healthy minimum of 15. It has increased from -5.89 (Mar 15) to 0.10, marking an increase of 5.99.
- For Return on Capital Employeed (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -3.15 (Mar 15) to 0.00, marking an increase of 3.15.
- For Return On Assets (%), as of Mar 16, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -4.60 (Mar 15) to 0.08, marking an increase of 4.68.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.00. It has decreased from 0.01 (Mar 15) to 0.00, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 2.49. This value is within the healthy range. It has decreased from 13.52 (Mar 15) to 2.49, marking a decrease of 11.03.
- For Quick Ratio (X), as of Mar 16, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 3.61 (Mar 15) to 0.62, marking a decrease of 2.99.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 67.43. This value is within the healthy range. It has increased from -4,912.48 (Mar 15) to 67.43, marking an increase of 4,979.91.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -11.85. This value is below the healthy minimum of 3. It has increased from -8,831.33 (Mar 15) to -11.85, marking an increase of 8,819.48.
- For Enterprise Value (Cr.), as of Mar 16, the value is 7.47. It has increased from -1.79 (Mar 15) to 7.47, marking an increase of 9.26.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -3.32 (Mar 15) to 0.00, marking an increase of 3.32.
- For EV / EBITDA (X), as of Mar 16, the value is 404.43. This value exceeds the healthy maximum of 15. It has increased from 1.35 (Mar 15) to 404.43, marking an increase of 403.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.13 (Mar 15) to 0.00, marking a decrease of 8.13.
- For Price / BV (X), as of Mar 16, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.11 (Mar 15) to 0.33, marking an increase of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.14 (Mar 15) to 0.00, marking a decrease of 8.14.
- For EarningsYield, as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.52 (Mar 15) to 0.00, marking an increase of 0.52.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morgan Ventures Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.1% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -11.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 3.04 (Industry average Stock P/E: 73.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 37, Ring Road, Lajpat Nagar - IV, New Delhi Delhi 110024 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kuldeep Kumar Dhar | Managing Director |
| Mr. Sanjiv Bansal | Independent Director |
| Mr. Yogesh Kumar Gupta | Independent Director |
| Mrs. Madhu | Woman Director |
FAQ
What is the intrinsic value of Morgan Ventures Ltd?
Morgan Ventures Ltd's intrinsic value (as of 10 February 2026) is ₹94.53 which is 34.28% higher the current market price of ₹70.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹69.7 Cr. market cap, FY2025-2026 high/low of ₹127/64.8, reserves of ₹86 Cr, and liabilities of ₹295 Cr.
What is the Market Cap of Morgan Ventures Ltd?
The Market Cap of Morgan Ventures Ltd is 69.7 Cr..
What is the current Stock Price of Morgan Ventures Ltd as on 10 February 2026?
The current stock price of Morgan Ventures Ltd as on 10 February 2026 is ₹70.4.
What is the High / Low of Morgan Ventures Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morgan Ventures Ltd stocks is ₹127/64.8.
What is the Stock P/E of Morgan Ventures Ltd?
The Stock P/E of Morgan Ventures Ltd is 3.04.
What is the Book Value of Morgan Ventures Ltd?
The Book Value of Morgan Ventures Ltd is 97.3.
What is the Dividend Yield of Morgan Ventures Ltd?
The Dividend Yield of Morgan Ventures Ltd is 0.00 %.
What is the ROCE of Morgan Ventures Ltd?
The ROCE of Morgan Ventures Ltd is 18.3 %.
What is the ROE of Morgan Ventures Ltd?
The ROE of Morgan Ventures Ltd is 32.0 %.
What is the Face Value of Morgan Ventures Ltd?
The Face Value of Morgan Ventures Ltd is 10.0.